Accueil>>Signaling Pathways>> Immunology/Inflammation>> STING>>diABZI STING agonist-1 Tautomerism

diABZI STING agonist-1 Tautomerism

Catalog No.GC35854

diABZI STING agonist-1 Le tautomérisme (composé 3) est un stimulateur sélectif de l'agoniste des récepteurs des gènes de l'interféron (STING), avec des CE50 de 130, 186 nM pour l'homme et la souris, respectivement.

Products are for research use only. Not for human use. We do not sell to patients.

diABZI STING agonist-1 Tautomerism Chemical Structure

Cas No.: 2138498-18-5

Taille Prix Stock Qté
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 for human PBMCs. EC50: 130 nM (human STNG in PBMCs) [1].

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 for human PBMCs.

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. At a concentration of 1 μM, diABZI STING agonist-1 (compound 3) demonstrates high selectivity against more than 350 kinases tested[1].

[1]. Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018 Nov 7.

Avis

Review for diABZI STING agonist-1 Tautomerism

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for diABZI STING agonist-1 Tautomerism

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.